CoreCap Advisors’s AstraZeneca AZN Stock Holding History

CoreCap Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$98.4K	Buy	+519	New	+$97.6K	﹤0.01%	1108
2026 Q1	–	Sell	-362	Closed	-$66.5K	–	2949
2025 Q4	$66.5K	Buy	362 +95	+36%	+$16.7K	﹤0.01%	1191
2025 Q3	$41K	Buy	267 +62	+30%	+$9.38K	﹤0.01%	1403
2025 Q2	$28.6K	Sell	205 -45	-18%	-$6.31K	﹤0.01%	1476
2025 Q1	$36.7K	Sell	250 -71	-22%	-$10.3K	﹤0.01%	1300
2024 Q4	$42.1K	Buy	321 +77	+32%	+$10.8K	﹤0.01%	1262
2024 Q3	$37.9K	Buy	+244	New	+$39.4K	﹤0.01%	1311
2024 Q2	–	Sell	-202	Closed	-$27.4K	–	1681
2024 Q1	$27.4K	Buy	+202	New	+$26.7K	﹤0.01%	1345
2022 Q4	$52.8K	Buy	+389	New	+$48.8K	﹤0.01%	969
2022 Q3	–	Sell	-247	Closed	-$33K	–	657
2022 Q2	$33K	Sell	247 -1,715	-87%	-$225K	﹤0.01%	1076
2022 Q1	$260K	Sell	1,962 -55	-3%	-$6.6K	0.02%	439
2021 Q4	$235K	Buy	+2,017	New	+$237K	0.02%	500

Other funds holding AZN

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

CAM

Cidel Asset Management Toronto, Ontario, Ontario, Canada $2.08B AUM 24.89% 1-Year Est. Return

SAM

Sycomore Asset Management Paris, France $932M AUM 51.25% 1-Year Est. Return

PAS

Professional Advisory Services Vero Beach, Florida $836M AUM 25.79% 1-Year Est. Return

CoreCap Advisors's AZN Position: Q2 2026 in Review

CoreCap Advisors opened a new position in AstraZeneca (AZN) in Q2 2026: 519 shares worth $98.4K. The stake represents ﹤0.01% of the portfolio and ranks #1108 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in AZN as recently as Q4 2025.

CoreCap Advisors first reported a position in AZN in Q4 2021 and has held it in 12 quarters since. The position peaked at $260K in Q1 2022. 253 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

CoreCap Advisors held 519 shares of AstraZeneca worth $98.4K as of Q2 2026.
AstraZeneca was a new CoreCap Advisors position in Q2 2026.
AstraZeneca made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1108 holding.
CoreCap Advisors first reported a position in AstraZeneca in Q4 2021 and has held it in 12 quarters since.
CoreCap Advisors's AstraZeneca position peaked at $260K in Q1 2022.
253 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.